TED Member States· European UniontenderOpen · 19 Oct 2026
Kardiaka 15 - Acoramidis
Institut klinické a experimentální medicíny
Deadline 19 Oct 2026Deadline19 Oct 2026
Estimated valueCZK 256,400,000
CPV category33622100
Published17 Sep 2026
Reference649006-2026
Notice summary
The subject of the public contract is the regular supply of medicinal products containing the active substance acoramidis (ATC group C01EB25) for the treatment of patients in approved indications according to SmPC C and according to the indication limitation of reimbursement valid on the date of submission of bids.
Is this worth bidding on?
Tender Radar scores every tender against your company profile, surfaces the matching services, and flags the ones worth your time — across Europe and beyond. Sign in to see the relevance match and full AI analysis for this opportunity.